We are pleased to announce that we will be hosting a Lhasa Limited Symposium in Shanghai, China, alongside CloudScientific.
On 17th October 2024, we will be bringing together professionals from industry to address critical topics on on impurity assessment and control in drug development and manufacturing.
The event will offer valuable insights from experts on ICH M7 assessment, process and degradation impurities, and the application of innovative in silico tools – helping attendees to better understand relevant regulations, and apply the latest technologies for impurity control.
External guest speakers include:
- Jack Lin, CEO, CloudScientific
- Peng She, Director of R&D Analysis, Small Molecule Division, Porton Pharma Solutions
- Dr Mike Urquhart, Scientific Director, Drug Substance Development, GSK
- Dr Lirong Cai, Engineer of Pharmaceutical Excipients Key Laboratory, Hunan Institute
- Luccas Sanches, Researcher, Spektra Consulting
9:00 – 16:00 – Symposium
Session 1: ICH M7 Assessments
Session 2: Elemental Impurities in Drug Products
Session 3: Process and Degradation Impurities
16:00 – Networking and demonstrations
Simultaneous interpretation and lunch will be provided.
View the full agenda:
Please contact us with any questions.